Month: April 2021

STOCKHOLM – April 7, 2021 – ContextVision hereby invites shareholders to the Annual General Meeting on May 5, 2021. Please find attached the invitation including agenda and details on how to register and vote. Please contact: finance@contextvision.se for any questions regarding the AGM. For inquiries, please contact CFO Ann-Charlotte LinderothE-mail: ann-charlotte.linderoth@contextvision.se ### About ContextVisionContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge...

STOCKHOLM – 7 april, 2021 – ContextVision kallar härmed aktieägare till årsstämma den 5:e maj 2021. Bifogat finns kallelse inklusive dagordning och instruktioner för registrering och röstning. Vänligen kontakta: finance@contextvision.se för frågor gällande årsstämman. För övriga frågor, vänligen kontakta CFO Ann-Charlotte LinderothE-post: ann-charlotte.linderoth@contextvision.se ### Om ContextVisionContextVision är ett medicintekniskt mjukvaruföretag specialiserat på bildanalys och artificiell intelligens. Som den globala marknadsledaren inom bildbehandling är vi en etablerad partner till ledande tillverkare av ultraljud, röntgen och magnetkamerautrustning runt om i världen. Vår expertis är att utveckla kraftfulla mjukvaruprodukter baserade på egenutvecklad teknologi och artificiell intelligens för bildbaseradetillämpningar. Våra högteknologiska...

Data from Initial Patient Cohorts of Phase 2 AFFINITY Study Expected to be Reported in 2022 SEATTLE, April 07, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that the first patient has been dosed in the AFFINITY Study, a phase 2 clinical trial evaluating the efficacy and safety of atrasentan, a potent and selective inhibitor of the endothelin A receptor, in patients with proteinuric glomerular disease who are at risk of progressive loss of renal function. “Initiation of the phase 2 AFFINITY Study is an important step in evaluating atrasentan across multiple proteinuric glomerular diseases for which there are currently limited treatment options,” said Alan Glicklich,...

Announcement no. 11 2021 Copenhagen – 7 April 2021 – Agillic A/S (Nasdaq First North Growth Market Denmark: AGILC), the Copenhagen-based marketing automation Software-as-a-Service (SaaS) company announces, that it has elected Susanne Lund as a new member of the board of directors and has extended its shared-based incentive program with 105,500 new warrants.  On the ordinary annual general meeting 30 March 2021, Susanne Lund was elected as new member of Agillic’s board of directors. At the same time, Peter Elbek stepped down from the board of directors. Says Johnny Henriksen, chair of Agillic: “I am delighted to welcome Susanne Lund to the board of directors and to announce that Agillic has extended the Company’s current warrant program as part of the Company’s reboot 2.1 strategy. A key element in the strategy...

NEW YORK, April 07, 2021 (GLOBE NEWSWIRE) — Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today announced the Company will hold a conference call to review its first quarter 2021 financial results on Friday, April 23, 2021 at 10:00 a.m. Eastern Time. The Company’s first quarter 2021 financial results will be released after the market closes on Thursday, April 22, 2021. During the conference call, Company officers will review first quarter 2021 performance, discuss recent events and conduct a question-and-answer period. Teleconference Details:Members of the public who are interested in participating in the Company’s first quarter 2021 earnings teleconference call should dial from the U.S., (877) 331-6553, or from outside the U.S., (760) 666-3769, shortly before 10:00 a.m. and reference the Apollo...